Cargando…
Thrombosis in Systemic Lupus Erythematosus: A Review Article
Thrombosis is a well-known clinical entity in systemic lupus erythematosus (SLE), and it is multifactorial. The most important risk factor is the presence of antiphospholipid antibodies (APLAs). However, approximately 40% of adults with SLE who are negative for APL A are diagnosed with thrombosis, i...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
International Scholarly Research Network
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413961/ https://www.ncbi.nlm.nih.gov/pubmed/22900201 http://dx.doi.org/10.5402/2012/428269 |
| _version_ | 1782240124611854336 |
|---|---|
| author | Al-Homood, Ibrahim A. |
| author_facet | Al-Homood, Ibrahim A. |
| author_sort | Al-Homood, Ibrahim A. |
| collection | PubMed |
| description | Thrombosis is a well-known clinical entity in systemic lupus erythematosus (SLE), and it is multifactorial. The most important risk factor is the presence of antiphospholipid antibodies (APLAs). However, approximately 40% of adults with SLE who are negative for APL A are diagnosed with thrombosis, indicating the importance of other risk factors. Thus, the thrombosis risk factors should be evaluated extensively and regularly and treated aggressively in every patient with systemic lupus erythematosus. |
| format | Online Article Text |
| id | pubmed-3413961 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2012 |
| publisher | International Scholarly Research Network |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-34139612012-08-16 Thrombosis in Systemic Lupus Erythematosus: A Review Article Al-Homood, Ibrahim A. ISRN Rheumatol Review Article Thrombosis is a well-known clinical entity in systemic lupus erythematosus (SLE), and it is multifactorial. The most important risk factor is the presence of antiphospholipid antibodies (APLAs). However, approximately 40% of adults with SLE who are negative for APL A are diagnosed with thrombosis, indicating the importance of other risk factors. Thus, the thrombosis risk factors should be evaluated extensively and regularly and treated aggressively in every patient with systemic lupus erythematosus. International Scholarly Research Network 2012-07-30 /pmc/articles/PMC3413961/ /pubmed/22900201 http://dx.doi.org/10.5402/2012/428269 Text en Copyright © 2012 Ibrahim A. Al-Homood. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Review Article Al-Homood, Ibrahim A. Thrombosis in Systemic Lupus Erythematosus: A Review Article |
| title | Thrombosis in Systemic Lupus Erythematosus: A Review Article |
| title_full | Thrombosis in Systemic Lupus Erythematosus: A Review Article |
| title_fullStr | Thrombosis in Systemic Lupus Erythematosus: A Review Article |
| title_full_unstemmed | Thrombosis in Systemic Lupus Erythematosus: A Review Article |
| title_short | Thrombosis in Systemic Lupus Erythematosus: A Review Article |
| title_sort | thrombosis in systemic lupus erythematosus: a review article |
| topic | Review Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413961/ https://www.ncbi.nlm.nih.gov/pubmed/22900201 http://dx.doi.org/10.5402/2012/428269 |
| work_keys_str_mv | AT alhomoodibrahima thrombosisinsystemiclupuserythematosusareviewarticle |